Effects of selenium on oxidative stress and glycemic control of type 2 diabetes - Trial IRCT138901203667N1
Access comprehensive clinical trial information for IRCT138901203667N1 through Pure Global AI's free database. This Phase 4 trial is sponsored by Vice-chancellor for Research, Tehran University of Medical Sciences and is currently Completed. The study focuses on Diabetes Mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
IRCT138901203667N1
Phase 4
Completed
drug
Trial Details
Iranian Registry Of Clinical Trial • IRCT138901203667N1
Effects of selenium on oxidative stress and glycemic control of type 2 diabetes
Study Focus
Sponsor & Location
Vice-chancellor for Research, Tehran University of Medical Sciences
Iran
Timeline & Enrollment
Phase 4
Feb 20, 2010
N/A
ICD-10 Classifications
Diabetes mellitus
Unspecified diabetes mellitus
Other specified diabetes mellitus
Unspecified diabetes mellitus without complications
Unspecified diabetes mellitus with unspecified complications
Data Source
Iranian Registry Of Clinical Trial
IRCT138901203667N1
Non-Device Trial